Online Evaluation of the Diagnostic Accuracy of BlinkLab's Digital Assessments for Autism (NCT07590973)
๐ฉบ Plain-English Summary (8th-Grade Level)
This observational study aims to evaluate how patterns of behavioral and sensorimotor responses measured using the BlinkLab Dx1 smartphone application relate to autism diagnoses in children ages 2 to 11. BlinkLab Dx1 is a non-invasive, smartphone-based application under development as a diagnostic aid for healthcare providers assessing autism. In this study, children who have undergone a neurodevelopmental assessment within the past 12 months will complete two short, video-based sessions using the BlinkLab Dx1 app. The app presents visual and auditory stimuli and records reflexive sensorimotor responses and patterns of repetitive behavior. Additionally, primary caregivers will answer a short questionnaire in the app about symptoms and development. Information about prior neurodevelopmental assessments, including documented DSM-5-based diagnoses from routine clinical practice, will be collected retrospectively. The study will examine how the app's neurobehavioral measurements relate to previously assigned clinical diagnoses. These paired data will be used to develop and evaluate a machine learning-based algorithm using separate training and testing datasets to assess whether patterns measured by BlinkLab Dx1 can help distinguish children with autism from children without an autism diagnosis. This study does not involve any treatment or medical intervention.
Who can join: Review the eligibility criteria below.
Location: Remote study conducted nationwide; all participation occurs via smartphone app at home. โ Princeton, New Jersey
Age range: 2 Years to 11 Years
๐งช Interventions in This Study
- BlinkLab Dx1 (DIAGNOSTIC_TEST)
- Retrospective Neurodevelopmental Diagnostic Assessment (BEHAVIORAL)
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (1 Sites)
- Remote study conducted nationwide; all participation occurs via smartphone app at home. โ Princeton, New Jersey
๐ Contact the Study Coordinator
Phone: (908) 824-3471
Email: study@blinklab.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Autism
- The Effectiveness of an Autistic-delivered Peer-support Intervention for Autistic Adults: Community Autism Peer Specialist (CAPS) Program โ Philadelphia, Pennsylvania
- Trial of Cannabidiol to Treat Severe Behavior Problems in Children With Autism โ La Jolla, California
- Developing Treatment, Treatment Validation and Treatment Scope in the Setting of an Autism Clinical Trial โ Piscataway, New Jersey
- Culturally Adapted RUBI for Spanish-Speaking Families in Texas and Mexico โ Waco, Texas
- An Open Label Study of CM-AT for the Treatment of Children With Autism โ Phoenix, Arizona
- Sulforaphane in a New Jersey (NJ) Population of Individuals With Autism โ Piscataway, New Jersey
Explore by condition: All Autism clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.